Evidence map›Paper›PMID 41695940›Full record

ReviewWorld journal of gastrointestinal oncology2026

Recent advances in spasmolytic polypeptide expressing metaplasia research.

Rui-Rui Yang, Ya-Ru Yan, Yu-Feng Li

Abstract readReview
In one paragraph

Review in World journal of gastrointestinal oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Rui-Rui YangFirst Clinical School, Liaoning University of Chinese Medicine, Shenyang 110847, Liaoning Province, China.
Ya-Ru YanHeilongjiang Provincial Academy of Traditional Chinese Medicine, Harbin 150036, Heilongjiang Province, China.
Yu-Feng LiDepartment of Gastroenterology, Affiliated Hospital of Liaoning University of Traditional Chinese Medicine, Shenyang 110847, Liaoning Province, China. 3278086072@qq.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gastric cancer remains a leading cause of global cancer mortality, with limited advances in its prevention and treatment owing to an incomplete understanding of its pathogenesis. Among the key precancerous lesions, spasmolytic polypeptide-expressing metaplasia has emerged as a critical driver in gastric carcinogenesis. This review summarizes the recent advances in the mechanistic roles of spasmolytic polypeptide-expressing metaplasia in gastric mucosal diseases. By elucidating these pathways, this review sought to provide novel insights that could inform future strategies for early intervention and prevention of gastric cancer.

Indexed as

Gastric adenocarcinomaPathogenesisResearch progressSignaling pathwaySpasmolytic polypeptide-expressing metaplasia

Identifiers

PMID41695940
PMCPMC12898106

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.